Pulse Explore Journal Club Debates Trending Researchers

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

Home Explore Journal Club Trending

⌘+K

Time to Significant Benefit of Finerenone in Patients With Heart Failure | Synapse

September 28, 2024Open Access

Time to Significant Benefit of Finerenone in Patients With Heart Failure

Key Result

Finerenone provides a significant clinical benefit over time in patients with heart failure.

Main Result

Absolute Event Rate: 0% vs 0%

Abstract

International audience

Ask AI

Helpful

Bookmark

Share

View Full Paper

Ask AI

Helpful

Bookmark

Share

View Full Paper

Cite This Study

Vaduganathan et al. (Sat,) reported a other. Finerenone provides a significant clinical benefit over time in patients with heart failure.

synapsesocial.com/papers/6a1788f32540ce62a354f371 https://doi.org/https://doi.org/10.1016/j.jacc.2024.09.018

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Effect of Finerenone on Chronic Kidney Disease Outcomes in Type 2 Diabetes2020 · 2,689 citations
2Regional Variation in Patients and Outcomes in the Treatment of Preserved Cardiac Function Heart Failure With an Aldosterone Antagonist (TOPCAT) Trial2014 · 1,042 citations
3Dapagliflozin in Heart Failure with Mildly Reduced or Preserved Ejection Fraction2022 · 2,687 citations
4Empagliflozin in Heart Failure with a Preserved Ejection Fraction2021 · 4,651 citations
5Finerenone in Heart Failure with Mildly Reduced or Preserved Ejection Fraction2024 · 733 citations